Collplant Biotechnologies Ltd
CLGN0.800USD
+0.050+6.65%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
10.22M시가총액
손실P/E TTM
자세한 내용은 Collplant Biotechnologies Ltd 회사
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Collplant Biotechnologies Ltd 정보
종목 코드 CLGN
회사 이름Collplant Biotechnologies Ltd
상장일Sep 01, 1993
CEORotem (Eran)
직원 수57
유형Ordinary Share
회계 연도 종료Sep 01
주소4 Oppenheimer Street
도시REHOVOT
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호7670104
전화972732325600
웹사이트https://www.collplant.com
종목 코드 CLGN
상장일Sep 01, 1993
CEORotem (Eran)
Collplant Biotechnologies Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
31.14K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
2.00K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
Dr. Elan Penn, Ph.D.
Dr. Elan Penn, Ph.D.
Independent Director
Independent Director
--
--
Dr. Roger J. Pomerantz, M.D.
Dr. Roger J. Pomerantz, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
31.14K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
2.00K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q2
FY2024
FY2024Q2
FY2023
FY2023Q2
FY2022
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Revenues from the sales of goods
179.00K
0.00%
지역별USD
이름
수익
비율
Northern America
159.00K
88.83%
Europe
20.00K
11.17%
사업별
지역별
사업별USD
이름
수익
비율
Revenues from the sales of goods
179.00K
0.00%
주식 보유 통계
마지막 업데이트: Sat, Nov 15
마지막 업데이트: Sat, Nov 15
주주
주주 유형
주주
주주
비율
Sagy (Ami)
12.81%
Loewenbaum (George Walter II)
9.83%
St. Denis J. Villere & Company, LLC
4.75%
Pinnacle Associates Ltd.
4.36%
Loewenbaum (Lilian Shaw)
3.18%
기타
65.06%
주주
주주
비율
Sagy (Ami)
12.81%
Loewenbaum (George Walter II)
9.83%
St. Denis J. Villere & Company, LLC
4.75%
Pinnacle Associates Ltd.
4.36%
Loewenbaum (Lilian Shaw)
3.18%
기타
65.06%
주주 유형
주주
비율
Individual Investor
29.81%
Investment Advisor
7.56%
Investment Advisor/Hedge Fund
5.38%
Hedge Fund
1.74%
Research Firm
0.14%
Family Office
0.13%
기타
55.25%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
34
1.82M
18.05%
--
2025Q3
36
1.82M
18.09%
-351.44K
2025Q2
36
2.17M
13.51%
+569.42K
2025Q1
36
2.09M
19.82%
-180.41K
2024Q4
38
2.54M
24.36%
-57.22K
2024Q3
40
2.59M
23.16%
+143.75K
2024Q2
40
2.45M
24.33%
+72.69K
2024Q1
40
2.38M
24.25%
-401.71K
2023Q4
45
2.39M
26.23%
-101.34K
2023Q3
46
2.49M
28.02%
-60.71K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Sagy (Ami)
1.64M
12.81%
-306.10K
-15.75%
Nov 19, 2025
Loewenbaum (George Walter II)
1.26M
9.83%
--
--
Nov 06, 2025
St. Denis J. Villere & Company, LLC
588.72K
4.61%
+41.85K
+7.65%
Sep 30, 2025
Pinnacle Associates Ltd.
507.19K
3.97%
--
--
Sep 30, 2025
Loewenbaum (Lilian Shaw)
406.29K
3.18%
-245.19K
-37.64%
Nov 06, 2025
Evans (Hugh M)
377.43K
2.95%
-1.00
-0.00%
Mar 15, 2025
Roumell Asset Management, L.L.C.
276.43K
2.16%
-38.86K
-12.32%
Jun 30, 2024
AMH Equity, Ltd.
200.00K
1.57%
+39.15K
+24.34%
Sep 30, 2025
Brown Advisory
118.73K
0.93%
+7.55K
+6.79%
Sep 30, 2025
Benjamin F. Edwards & Company, Inc.
39.76K
0.31%
-10.69K
-21.19%
Jun 30, 2024
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
